psma positive cell line lncap (ATCC)
Structured Review
![Retention of [ 89 Zr]Zr-A11 and [ 89 Zr]Zr-A12 in PSMA + <t>LNCAP</t> tumors (●; black symbol and line) and PSMA − PC-3 tumors ( ● ; red symbol and line). Tumor-bearing mice ( n = 4 or 5 per group) were injected with either [ 89 Zr]Zr-A12 or [ 89 Zr]Zr-A11 via the tail vein. When comparing the radioactivity retention at 1 h, 4 h and 24 h, animals receiving [ 89 Zr]Zr-A12 had significantly more radioactivity associated with PSMA + tumors than PSMA − tumors at 1h ( p = 0.002), 4h ( p = 0.004) and 24h ( p = 0.003). Contrarily, when comparing the radioactivity retention at 1 h, 4 h and 24 h for animals receiving [ 89 Zr]Zr-A11, the retention of radioactivity in PSMA + and PSMA − tumors was non-significant at 1 h ( p = 0.6), 4 h ( p = 0.8) and 24 h ( p = 0.3).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_9641/pmc12899641/pmc12899641__molecules-31-00493-g003.jpg)
Psma Positive Cell Line Lncap, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2671 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/psma+positive+cell+line+lncap/LNCaP+clone+FGC/pmc12899641-184-1-15
Average 99 stars, based on 2671 article reviews
Images
1) Product Images from "Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate Cancer"
Article Title: Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate Cancer
Journal: Molecules
doi: 10.3390/molecules31030493
Figure Legend Snippet: Retention of [ 89 Zr]Zr-A11 and [ 89 Zr]Zr-A12 in PSMA + LNCAP tumors (●; black symbol and line) and PSMA − PC-3 tumors ( ● ; red symbol and line). Tumor-bearing mice ( n = 4 or 5 per group) were injected with either [ 89 Zr]Zr-A12 or [ 89 Zr]Zr-A11 via the tail vein. When comparing the radioactivity retention at 1 h, 4 h and 24 h, animals receiving [ 89 Zr]Zr-A12 had significantly more radioactivity associated with PSMA + tumors than PSMA − tumors at 1h ( p = 0.002), 4h ( p = 0.004) and 24h ( p = 0.003). Contrarily, when comparing the radioactivity retention at 1 h, 4 h and 24 h for animals receiving [ 89 Zr]Zr-A11, the retention of radioactivity in PSMA + and PSMA − tumors was non-significant at 1 h ( p = 0.6), 4 h ( p = 0.8) and 24 h ( p = 0.3).
Techniques Used: Injection, Radioactivity
Related Articles
Injection:Article Title: Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate Cancer Article Snippet: The poly-L-lysine-coated Corning BioCoat coverslips were obtained from ThermoFisher Scientific, Inc.The poly-L-lysine-coated Corning BioCoat coverslips were obtained from ThermoFisher Scientific, Inc.. The PSMA-positive cell line LNCaP ( Radioactivity:Article Title: Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate Cancer Article Snippet: The poly-L-lysine-coated Corning BioCoat coverslips were obtained from ThermoFisher Scientific, Inc.The poly-L-lysine-coated Corning BioCoat coverslips were obtained from ThermoFisher Scientific, Inc.. The PSMA-positive cell line LNCaP ( |
